Mar­ket­ingRx roundup: Bio­gen be­gins so­cial aware­ness around post­par­tum de­pres­sion; Phar­ma mar­keters in the NBA games

As Bio­gen and Sage Ther­a­peu­tics await an FDA de­ci­sion on post­par­tum de­pres­sion (PPD) can­di­date zu­ra­nolone, they’re tak­ing the first steps to dri­ve aware­ness of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER